These functions overlap substantially with the central functions of SIRT6 in controlling cancer cell metabolism; however, we found that the increased expression and histone hyperacetylation of SIRT6 target glycolytic genes that occurs in SIRT6-deficient cells was not significantly rescued by ACLY inhibition. The gene discussed is ACLY; the disease is cancer.